fluorobenzenes has been researched along with Achondroplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, K; Ikegawa, S; Kimura, T; Kishi, H; Morioka, M; Okada, M; Sawai, H; Tsumaki, N; Yahara, Y; Yamashita, A | 1 |
1 other study(ies) available for fluorobenzenes and Achondroplasia
Article | Year |
---|---|
Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Topics: Achondroplasia; Animals; Bone Development; Cartilage; Cell Differentiation; Chondrocytes; Disease Models, Animal; Female; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Induced Pluripotent Stem Cells; Lovastatin; Male; Mice; Mice, Inbred C57BL; Phenotype; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 3; Rosuvastatin Calcium; Sulfonamides; Thanatophoric Dysplasia | 2014 |